San Antonio—For those engaged in the ongoing saga of Uber and Lyft versus fingerprinting, the next date to mark is in October, at least in the Alamo City.
Uber, Lyft, and Get Me will be able to continue offering rides... Read more »
[Corrected 6/30/16, 2:49 p.m. See below.] Google Capital’s $46.35 million investment in publicly traded Care.com, announced Wednesday, marked a departure from the firm’s usual bets on late-stage private companies and illustrated how the traditional lines in the venture capital... Read more »
Reflexion Health, a San Diego startup founded in 2012 at the nonprofit West Health Institute, is moving to commercialize Vera, its physical rehabilitation system based on Microsoft Kinect’s motion tracking technology.
After recently raising $18 million in Series B funding, the... Read more »
Roboticists covered a sweeping range of topics at Xconomy’s annual Robo Madness West conference last week, from the ethics of artificial intelligence to the powerful impact of robots that have faces.
Two themes ran through all the panel discussions, whether they... Read more »
Moderna Therapeutics still hasn’t produced data in humans supporting its technology, which is meant to turn our bodies into little drugmaking factories. But the Cambridge, MA-based company nonetheless keeps grabbing the attention, and cash, of other drugmakers.
Moderna said today that... Read more »
The expertise and guidance of a savvy mentor can change the fortunes of a startup.
Here’s a look at innovation news from around Michigan:
—Wayne State University and Massachusetts General Hospital spinout company RetroSense Therapeutics has been named one of the nation’s 50 smartest companies by the MIT Technology Review. The biopharmaceutical company based in... Read more »
Dallas—With the dismissal of two top executives from Dallas’s Tech Wildcatters, the startup accelerator has made a deep pivot in operations since its founding seven years ago.
Molly Cain, TW’s executive director, and Clarisa Lindenmeyer, chief revenue officer, were both... Read more »
Icagen is expanding its capabilities to search for new drugs by bolting on a Sanofi research site in Arizona and gaining access to the lab’s library of compounds.
The Boston-area cybersecurity scene is ripe with acquisition targets. IBM bought incident-response firm Resilient Systems earlier this year. Now, Cisco Systems says it is acquiring CloudLock, a Waltham, MA-based cloud security company, for $293 million in cash and stock, plus... Read more »
Modern Meadow, a New York-based company that has developed a method of turning living cells into materials used to make leather that mimics animal hide, has received a $40 million Series B funding to begin manufacturing and commercializing its leather products.... Read more »
Every day it seems a new tech startup emerges to tap the keg of the spirits industry, especially on the consumer delivery side. The team at New York’s SevenFifty took on a different approach, however, trying to fix inefficiencies in the... Read more »
The outlook for Infinity Pharmaceuticals didn’t look good after its blood cancer drug, duvelisib, came up short in a critical clinical trial a few weeks ago, and the situation has gotten worse today. AbbVie has sent the rights to duvelisib back... Read more »
[Updated 6/28/16, 12:50pm. See below.] PureTech Health starts companies in cutting-edge areas of biomedical science and often owns them outright. Its latest aims to create software that listens for warning signs of depression in people’s speech patterns.
The unveiling... Read more »
Resin.io, a startup with headquarters in Seattle and employees scattered across the globe, has raised a $9 million funding round to further its work on tools for software development and deployment for connected devices.
The company’s prior backer, DFJ, invested in the... Read more »
A new wave of drugs has changed the way hepatitis C is treated. Regulus Therapeutics has not been part of that wave, but the company’s plans to join it took a big hit this afternoon.
Waltham, MA-based Forum Pharmaceuticals, which spent more than decade pursuing a drug for Alzheimer’s and other neurological diseases, is shutting down, Xconomy has learned.
According to a Forum spokesperson, the company will be closed “by the end of the week.” The... Read more »
Happy Monday from Xconomy Texas. Let’s get caught up on the latest innovation news in the state.
Just another billion-dollar exit for a Massachusetts company most people have never heard of. This one has an interesting backstory, in a field rife with consolidation and would-be deals.
Now that it’s clear automakers plan to take autonomous vehicles and mobility platforms to market in the near future, the industry is undergoing a transformation that, earlier this year, a General Motors executive described as being like cramming 50 years of... Read more »